MDxHealth SA (MDXH)

NASDAQ: MDXH · IEX Real-Time Price · USD
2.590
+0.130 (5.28%)
At close: Mar 28, 2024, 4:00 PM
2.580
-0.010 (-0.39%)
After-hours: Mar 28, 2024, 6:01 PM EDT
5.28%
Market Cap 67.95M
Revenue (ttm) 70.19M
Net Income (ttm) -43.10M
Shares Out 27.29M
EPS (ttm) -16.60
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 308,766
Open 2.480
Previous Close 2.460
Day's Range 2.480 - 2.780
52-Week Range 0.350 - 4.640
Beta -379,681.88
Analysts Strong Buy
Price Target 7.33 (+183.01%)
Earnings Date Mar 6, 2024

About MDXH

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October ... [Read more]

Sector Healthcare
IPO Date Nov 4, 2021
Employees 252
Stock Exchange NASDAQ
Ticker Symbol MDXH
Full Company Profile

Financial Performance

In 2023, MDxHealth's revenue was $70.19 million, an increase of 89.43% compared to the previous year's $37.05 million. Losses were -$43.10 million, -2.14% less than in 2022.

Financial Statements

Analyst Forecast

According to 4 analysts, the average rating for MDXH stock is "Strong Buy." The 12-month stock price forecast is $7.33, which is an increase of 183.01% from the latest price.

Price Target
$7.33
(183.01% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering

Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering IRVINE, CA, and HERSTAL, BELGIUM – March 12, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the “Company” or “md...

16 days ago - GlobeNewsWire

Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results

Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results 2023 revenue grew by 89% to $70.2 million; excluding GPS, revenues up 42% 2023 gross margin expanded by 10.7 percentage points o...

22 days ago - GlobeNewsWire

MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6

MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6

5 weeks ago - GlobeNewsWire

Mdxhealth Announces Resignation of Board Member

Mdxhealth Announces Resignation of Board Member IRVINE, CA, and HERSTAL, BELGIUM – February 16, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a commercial-stage pr...

5 weeks ago - GlobeNewsWire

MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue Guidance

MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue Guidance IRVINE, CA, and HERSTAL, BELGIUM – January 8, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDX...

2 months ago - GlobeNewsWire

MDxHealth Announces Completion of Transition to Single Listing on Nasdaq

NEWS RELEASE – REGULATED INFORMATION DECEMBER 18, 2023, 1:00 AM ET / 07:00 AM CET              MDxHealth Announces Completion of Transition to Single Listing on Nasdaq IRVINE, CA, and HERSTAL, BELGIUM...

3 months ago - GlobeNewsWire

MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nasdaq

NEWS RELEASE – REGULATED INFORMATION NOVEMBER 27, 2023, 1:00 am ET / 7:00 am CET MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nas...

4 months ago - GlobeNewsWire

MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference

NEWS RELEASE November 14, 2023, 4PM ET/ 22:00 CET MDxHealth to Participate in the 35 th Annual Piper Sandler Healthcare Conference IRVINE, CA, and HERSTAL, BELGIUM – November 14, 2023 – MDxHealth SA (...

4 months ago - GlobeNewsWire

MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2023

NEWS RELEASE – REGULATED INFORMATION 8 NOVEMBER 2023, 4:00PM EDT / 22:00 CET             MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2023 IRVINE, CA, and ...

5 months ago - GlobeNewsWire

MDxHealth Announces the Approval by its Shareholders of the Proposed Transition to a Sole Listing of Shares on Nasdaq, and Details of the Share Consolidation

NEWS RELEASE – REGULATED INFORMATION INSIDE INFORMATION NOVEMBER 6, 2023, 1:00 AM ET / 7:00 CET

5 months ago - GlobeNewsWire

MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8

NEWS RELEASE 25 OCTOBER 2023, 4PM ET / 22:00 CET MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8 Company to Host Conference Call with Live Q&A, November 8,...

5 months ago - GlobeNewsWire

Mdxhealth's New Share Capital Amount and New Number of Shares

NEWS RELEASE - REGULATED INFORMATION October 20, 2023 , 4:00 PM EDT / 22:00 CET

5 months ago - GlobeNewsWire

MDxHealth Reports Preliminary Q3-2023 Revenues

NEWS RELEASE – INSIDE AND REGULATED INFORMATION 9 OCTOBER 2023, 4PM ET / 22:00 CET             MDxHealth Reports Preliminary Q3-2023 Revenues IRVINE, CA, and HERSTAL, BELGIUM – October 9, 2023 – MDxHe...

6 months ago - GlobeNewsWire

MDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq and Convenes an Extraordinary General Shareholders Meeting

NEWS RELEASE – REGULATED INFORMATION INSIDE INFORMATION OCTOBER 2, 2023, 4:00pm ET / 22:00 CET

6 months ago - GlobeNewsWire

MDxHealth Reports Q2 and Half Year 2023 Results

NEWS RELEASE – REGULATED INFORMATION 23 AUGUST 202 3 , 4:00PM EDT / 22:00 CET

7 months ago - GlobeNewsWire

MDxHealth to Present Q2 and Half Year 2023 Financial Results and Corporate Update on August 23

NEWS RELEASE 10 AUGUST 202 3 , 4 PM ET / 22:00 CET

8 months ago - GlobeNewsWire

Cigna Expands Commercial and Medicare Advantage Coverage to Include Mdxhealth's Select mdx for Prostate Cancer Test

Expansion of coverage with Cigna now includes full menu of Company's precision diagnostic prostate cancer tests, representing more than 15 million lives under coverage.

Other symbols: CI
8 months ago - GlobeNewsWire

MDxHealth Announces Results of its Extraordinary General Shareholders' Meeting

NEWS RELEASE - REGULATED INFORMATION                 30 June 2023 , 10:00 p.m. CE S T

9 months ago - GlobeNewsWire

MDxHealth Announces its Extraordinary General Shareholders' Meeting

NEWS RELEASE – REGULATED INFORMATION JUNE 5 , 2023, 5 :30 pm ET/ 2 3 :30 CE S T MDxHealth Announces its Extraordinary General Shareholders' Meeting IRVINE, CA, and HERSTAL, BELGIUM – June 5, 2023 – MD...

10 months ago - GlobeNewsWire

MDxHealth Announces Results of its Annual and Extraordinary General Shareholders' Meetings

NEWS RELEASE - REGULATED INFORMATION                 25 May 2023 , 22:30 CET

11 months ago - GlobeNewsWire

MDxHealth to Present at the 43rd Annual William Blair Growth Stock Conference

NEWS RELEASE May 23 , 2023, 4 PM ET/ 22: 0 0 CET MDxHealth to Present at the 43 rd Annual William Blair Growth Stock Conference IRVINE, CA, and HERSTAL, BELGIUM – May 23, 2023 – MDxHealth SA (Nasdaq a...

11 months ago - GlobeNewsWire

MDxHealth Reports Q1-2023 Results

NEWS RELEASE - REGULATED INFORMATION 15 MAY 202 3 , 4:00PM EDT / 22:00 CET

11 months ago - GlobeNewsWire

MDxHealth to Present First Quarter 2023 Financial Results on May 15

NEWS RELEASE 1 MAY 202 3 , 4PM ET / 22 :00 CET

11 months ago - GlobeNewsWire

MDxHealth Announces its Ordinary and Extraordinary General Shareholders' Meetings

NEWS RELEASE – REGULATED INFORMATION APRIL 2 5 , 2023, 4: 00 pm ET/ 22: 00 CET

1 year ago - GlobeNewsWire